akusherstvoObstetrics, Gynecology and ReproductionАкушерство, Гинекология и Репродукция2313-73472500-3194IRBIS LLC10.17749/2070-4968.2015.9.3.028-034akusherstvo-169Research ArticleОRIGINAL ARTICLESОРИГИНАЛЬНЫЕ СТАТЬИANTITHROMBOTIC PROPHYLAXIS RECURRENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIAАнтитромботическая профилактика повторных преэклампсий у женщин с тромбофилиейЖуравлеваЕ. В.ZhuravlevaE. V.

к.м.н., научный сотрудник кафедры акушерства и гинекологии

MD, PhD, research associate of the Ob/Gyn Department

evyashenina@list.ruБицадзеВ. О.BitsadzeV. O.

д.м.н., профессор, профессор кафедры акушерства и гинекологии медико-профилактического факультета

MD., Professor, Department of Obstetrics and Gynecology, Faculty of Medical and Preventive

gemostasis@mail.ruМакацарияА. Д.MakatsariyaA. D.

д.м.н., член-корреспондент РАН, профессор, заведующий кафедрой акушерства и гинеко- логии медико-профилактического факультета

MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive

gemostasis@mail.ruГБОУ ВПО «Первый МГМУ имени И.М. Сеченова» Минздрава России, МоскваРоссияFirst Moscow State Medical Sechenov University of the Ministry of Health Russian FederationRussian Federation201519062016932834Copyright © Zhuravleva E.V., Bitsadze V.O., Makatsariya A.D., 20162016Журавлева Е.В., Бицадзе В.О., Макацария А.Д.Zhuravleva E.V., Bitsadze V.O., Makatsariya A.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gynecology.su/jour/article/view/169Преэклампсияантитромботическая профилактикаНМГтромбофилияPreeclampsiaantithrombotic therapyLMWGthrombophiliaReferencesAlfirevic Z., Roberts D. et al. How strong is the association between maternal thrombophilia and adverse pregnancy outcomes. A systematic review. Eur. J. Obstet. Gyn. Reprod. Biol. 2002; 101 (1): 6-14.Alfirevic Z., Roberts D. et al. How strong is the association between maternal thrombophilia and adverse pregnancy outcomes. A systematic review. Eur. J. Obstet. Gyn. Reprod. Biol. 2002; 101 (1): 6-14.Baimuradova S.M. Pathogenesis, principles of diagnosis and treatment of the syndrome of fetal loss due to acquired or genetic defects and hemostasis. Dr. diss. Moscow. 2007; 396 s.Baimuradova S.M. Pathogenesis, principles of diagnosis and treatment of the syndrome of fetal loss due to acquired or genetic defects and hemostasis. Dr. diss. Moscow. 2007; 396 s.Bitsadze V.O. Pathogenesis, principles of diagnosis and prevention of complications of pregnancy, due to thrombophilia. Dr. diss. Moscow. 2004; 251 s.Bitsadze V.O. Pathogenesis, principles of diagnosis and prevention of complications of pregnancy, due to thrombophilia. Dr. diss. Moscow. 2004; 251 s.Brenner B., Hoffman R., Blumenfeld Z. et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb. Haemost. 2000 May; 83 (5): 693-7.Brenner B., Hoffman R., Blumenfeld Z. et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb. Haemost. 2000 May; 83 (5): 693-7.Cervera R., Piette J.C., Font J. et al. EuroPhospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002. Apr; 46 (4): 1019-27.55.Cervera R., Piette J.C., Font J. et al. EuroPhospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002. Apr; 46 (4): 1019-27.55.Dossenbach-Glaninger A., van Trotsenburg M., Dossenbach M. et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin. Chem. 2003 Jul; 49 (7): 1081-6.Dossenbach-Glaninger A., van Trotsenburg M., Dossenbach M. et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin. Chem. 2003 Jul; 49 (7): 1081-6.Gris J.C., Mercier E., Quéré I. et al. Low-molecular-weight heparin versus low dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004 May 15; 103 (10): 3695-9.Gris J.C., Mercier E., Quéré I. et al. Low-molecular-weight heparin versus low dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004 May 15; 103 (10): 3695-9.Kovac M., Mitic G. et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol. Obstet. Invest. 2010; 69 (4): 233-8.Kovac M., Mitic G. et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol. Obstet. Invest. 2010; 69 (4): 233-8.Kupferminc M.J. Thrombophilia and pregnancy. Reprod. Biol. Endocrinol. 2003; 1: 111.Kupferminc M.J. Thrombophilia and pregnancy. Reprod. Biol. Endocrinol. 2003; 1: 111.Lyall Fiona, Belfort Michael, editors. Preeclampsia. Etiology and clinical practice. Cambridge, UK. 2007.Lyall Fiona, Belfort Michael, editors. Preeclampsia. Etiology and clinical practice. Cambridge, UK. 2007.Main E.K. Maternal mortality: new strategies for measurement and prevention. Curr. Opin. Obstet. Gynecol. 2010 Dec; 22 (6): 511-6.Main E.K. Maternal mortality: new strategies for measurement and prevention. Curr. Opin. Obstet. Gynecol. 2010 Dec; 22 (6): 511-6.Makatsariya A.D., Bitsadze V.O., Akin'shina S.V. Thrombosis and thromboembolism in obstetric practice. 2007; 151 s.Makatsariya A.D., Bitsadze V.O., Akin'shina S.V. Thrombosis and thromboembolism in obstetric practice. 2007; 151 s.Makatsariya A.D., Bitsadze V.O., Smirnova L.M., Akin'shina S.V., Baimuradova S.M. Thrombohemorrhagic complications in obstetric practice. Guidance for doctors Moscow. 2011; 1056 s.Makatsariya A.D., Bitsadze V.O., Smirnova L.M., Akin'shina S.V., Baimuradova S.M. Thrombohemorrhagic complications in obstetric practice. Guidance for doctors Moscow. 2011; 1056 s.National Institute for Clinical Excellence. Why Women die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom, 1997-1999. London. 2001.National Institute for Clinical Excellence. Why Women die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom, 1997-1999. London. 2001.Pandey M., Mantel G.D., Moodley J. Audit of severe acute morbidity in hypertensive pregnancies in a developing country. J. Obstet. Gynecol. 2004; 24: 387-391.Pandey M., Mantel G.D., Moodley J. Audit of severe acute morbidity in hypertensive pregnancies in a developing country. J. Obstet. Gynecol. 2004; 24: 387-391.Saving Mothers. Third Report on Confidential Enquiries into Maternal Deaths in South Africa 2002-2004. Department of Health, Pretoria.Saving Mothers. Third Report on Confidential Enquiries into Maternal Deaths in South Africa 2002-2004. Department of Health, Pretoria.Villar J., Abalos E., Nardin J.M., Merialdi M., Carroli G. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin. Nephrol. 2004; 24 (6): 607-15.Villar J., Abalos E., Nardin J.M., Merialdi M., Carroli G. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin. Nephrol. 2004; 24 (6): 607-15.

The authors declare that there are no conflicts of interest present.